Company Overview and News

0
Is Cree (CREE) Stock a Solid Choice Right Now?

2018-06-22 zacks
One stock that might be an intriguing choice for investors right now is Cree, Inc. (CREE - Free Report) . This is because this security in the Semiconductor – Discretes space is seeing solid earnings estimate revision activity and is in great company from a Zacks Industry Rank perspective.
CREE

114
3 Internet of Things Stocks to Buy Right Now

2018-06-19 investorplace
Semiconductor stocks have been the subject of unpredictable volatility so far this year, but the underlying business of this industry is growing—and should continue that trend in 2018 and beyond. Throughout the chip-making space, companies have successfully adapted to the changing needs of the consumer, including an increased demand for small, high-powered chips that enable “Internet of Things” (IoT) devices.
CY AMZN CREE VSH

37
3 "Internet of Things" Stocks to Buy Right Now

2018-06-18 zacks
Semiconductor stocks have been the subject of unpredictable volatility so far this year, but the underlying business of this industry is growing—and should continue that trend in 2018 and beyond. Throughout the chip-making space, companies have successfully adapted to the changing needs of the consumer, including an increased demand for small, high-powered chips that enable “Internet of Things” (IoT) devices.
HD CY CREE VSH

197
Looking Behind the Scenes in Semiconductors

2018-06-14 zacks
The semiconductor industry has been red hot this year, up 16.5% as a whole versus 4% for the S&P 500. Top industry players like Micron Technology (MU - Free Report) and Nvidia (NVDA - Free Report) have gotten the lion’s share of the attention from investors – and rightfully so as they have performed even better than the industry.
HD CREE MU VSH CSX NVDA 8035 TOELF YY TOELY

110
Strength Seen in Vishay Intertechnology (VSH): Stock Soars 13.3%

2018-06-08 zacks
Vishay Intertechnology, Inc. (VSH - Free Report) was a big mover last session, as the company saw its shares rise more than 13% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. The stock picked up sharply from the near-flat trend of $20.25 to $21.80 in the past one-month time frame. The company has not seen any estimate revisions in the past month, while its Zacks Consensus Estimate has moved higher over the same time frame, suggesting that more solid trading could be ahead for Vishay Intertechnology.
BRQS CREE MU VSH LB

3
CREE / Cree, Inc. FORM 8-K JUNE 7 2018 (Current Report)

2018-06-07 sec.gov
Document UNITED STATES
CREE

0
Why You Shouldn't Bet Against Cree, Inc. (CREE) Stock

2018-06-07 zacks
One stock that might be an intriguing choice for investors right now is Cree, Inc. (CREE - Free Report) . This is because this security in the Semiconductor - Discretes space is seeing solid earnings estimate revision activity and is in great company from a Zacks Industry Rank perspective. This is important because, often times, a rising tide will lift all boats in an industry, as there can be broad trends taking place in a segment that are boosting securities across the board.
CREE

2
CREE / Cree, Inc. FORM SD

2018-05-30 sec.gov
Document
CREE

45
General Electric: Recent Asset Sales Dramatically Increase Risks

2018-05-29 seekingalpha
This has carried over to its recent GE Transportation deal, which is friendly to shareholders but does little to lower the debt problem.
BHI GEC GE WAB CREE GNE SYF ETN

4
Cree (CREE) Shares March Higher, Can It Continue?

2018-05-22 zacks
As of late, it has definitely been a great time to be an investor in Cree, Inc. (CREE - Free Report) . The stock has moved higher by 12.8% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path.
CREE KHC

90
3 “Internet of Things” Stocks to Buy Right Now

2018-05-17 investorplace
Semiconductor stocks were hit hard by the recent market sell-off, but the underlying business of this industry is growing—and should continue that trend in 2018 and beyond. Throughout the chip-making space, companies have successfully adapted to the changing needs of the consumer, including an increased demand for small, high-powered chips that enable “Internet of Things” (IoT) devices.
AMZN CREE VSH

37
3 "Internet of Things" Stocks to Buy Right Now

2018-05-16 zacks
Semiconductor stocks were hit hard by the recent market sell-off, but the underlying business of this industry is growing—and should continue that trend in 2018 and beyond. Throughout the chip-making space, companies have successfully adapted to the changing needs of the consumer, including an increased demand for small, high-powered chips that enable “Internet of Things” (IoT) devices.
HD CY CREE VSH

0
BRIEF-Cree Says Compensation Committee Terminated Company's Severance Plan For Section 16 Officers, Dated August 18, 2008

2018-05-04 reuters
* CREE INC - ON APRIL 30, COMPENSATION COMMITTEE TERMINATED COMPANY’S SEVERANCE PLAN FOR SECTION 16 OFFICERS, DATED AUGUST 18, 2008 - SEC FILING
CREE

1
CREE / Cree, Inc. FORM 8-K MAY 4 2018 (Current Report)

2018-05-04 sec.gov
Document UNITED STATES
CREE

0
CREE / Cree, Inc. 10-Q (Quarterly Report)

2018-04-25 sec.gov
Document Table of Contents UNITED ST
CREE

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

Silicon Investor Message Boards

This table lists all message boards related to CREE / Cree, Inc. on message board site Silicon Investor.

Cree Inc. Screening for Stocks
Coldwater Creek Inc. (CWTR) Screening Criteria for Preferreds
BRUSH CREEK MINING AND DEVELOPMENT (BCMD) NEWS Stock screener
Stock screener Bear Creek Mining Corporation (500 million ounces silver)
Plains Creek Phosphate Corporation PCL: Plum Creek Timber Co. Inc
CUSIP: 225447101